Y-Intercept (HK)’s Regenxbio RGNX Stock Holding History

Y-Intercept (HK)’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17M	Sell	181,471 -93,550	-34%	-$776K	0.04%	652
2026 Q1	$2.3M	Buy	+275,021	New	+$2.89M	0.04%	651
2025 Q3	–	Sell	-176,999	Closed	-$1.45M	–	1962
2025 Q2	$1.45M	Buy	+176,999	New	+$1.48M	0.04%	757
2025 Q1	–	Sell	-137,402	Closed	-$1.06M	–	1542
2024 Q4	$1.06M	Buy	+137,402	New	+$1.29M	0.07%	404
2024 Q3	–	Sell	-38,844	Closed	-$454K	–	1728
2024 Q2	$454K	Buy	+38,844	New	+$605K	0.02%	858
2023 Q1	–	Sell	-11,859	Closed	-$269K	–	1476
2022 Q4	$269K	Buy	+11,859	New	+$268K	0.04%	710

Other funds holding RGNX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Y-Intercept (HK)'s RGNX Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Regenxbio (RGNX) stake by 34% in Q2 2026, selling an estimated $776K and leaving 181,471 shares worth $2.17M. The position accounts for 0.04% of the portfolio, ranked #652.

Y-Intercept (HK) first reported a position in RGNX in Q4 2022 and has held it in 6 quarters since. The position peaked at $2.3M in Q1 2026. 14 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Y-Intercept (HK) held 181,471 shares of Regenxbio worth $2.17M as of Q2 2026.
Y-Intercept (HK) sold 93,550 Regenxbio shares in Q2 2026, an estimated $776K.
Regenxbio made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #652 holding.
Y-Intercept (HK) first reported a position in Regenxbio in Q4 2022 and has held it in 6 quarters since.
Y-Intercept (HK)'s Regenxbio position peaked at $2.3M in Q1 2026.
14 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.